Bayer | BAYN - Equity Capital And Reserves

Stock Price
41.85
Daily Change
-0.74 -1.74%
Monthly
-10.46%
Yearly
83.97%
Q1 Forecast
42.20

Bayer reported EUR29.7B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Air Liquide EUR 26.21B 1.7B Dec/2025
Akzo Nobel EUR 4.66B 728M Dec/2025
Alcon AG USD 22.09B 44M Sep/2025
Amarin USD 458.89M 6.03M Sep/2025
Arkema EUR 6.12B 13M Sep/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
BASF EUR 32.76B 404M Sep/2025
Bayer EUR 29.7B 799M Sep/2025
Beiersdorf EUR 8.47B 7M Jun/2025
Corteva USD 24.14B 1.08B Dec/2025
Covestro EUR 6.09B 63M Sep/2025
Essilor EUR 38.89B 1.07B Dec/2025
Fresenius EUR 18.62B 320M Sep/2025
Fresenius Medical Care EUR 249.82M 12.7B Dec/2025
Genmab DKK 5.3B 6M Jun/2025
Givaudan CHF 4.31B 320M Jun/2024
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.18B 2.42B Sep/2025
Henkel EUR 20.04B 1.7B Jun/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Johnson Matthey GBP 2.1B 194M Dec/2025
Linde USD 40.09B 100M Sep/2025
Lonza CHF 9.33B 23M Dec/2024
Merck EUR 28.94B 677M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Nutrien USD 25.32B 206M Dec/2025
Philips EUR 10.58B 204M Sep/2025
PPG Industries USD 7.94B 141M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
SAP EUR 44.75B 1.94B Dec/2025
Solvay EUR 1.02B 245M Dec/2025
UCB EUR 10.03B 1.08B Dec/2024
Umicore EUR 2.24B 195.4M Dec/2025
Vinci EUR 28.62B 1.33B Jun/2025